BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23781326)

  • 1. Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma.
    Crona J; Verdugo AD; Granberg D; Welin S; Stålberg P; Hellman P; Björklund P
    Endocr Connect; 2013 Jun; 2(2):104-11. PubMed ID: 23781326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.
    Welander J; Andreasson A; Juhlin CC; Wiseman RW; Bäckdahl M; Höög A; Larsson C; Gimm O; Söderkvist P
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1352-60. PubMed ID: 24694336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
    McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.
    Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS
    Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.
    Crona J; Nordling M; Maharjan R; Granberg D; Stålberg P; Hellman P; Björklund P
    PLoS One; 2014; 9(1):e86756. PubMed ID: 24466223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours.
    Crona J; Maharjan R; Delgado Verdugo A; Stålberg P; Granberg D; Hellman P; Björklund P
    Fam Cancer; 2014 Mar; 13(1):121-5. PubMed ID: 23743562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore.
    Ting KR; Ong PY; Wei SOG; Parameswaran R; Khoo CM; Deepak DS; Lee SC
    Hered Cancer Clin Pract; 2020 Dec; 18(1):24. PubMed ID: 33308260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.
    Luchetti A; Walsh D; Rodger F; Clark G; Martin T; Irving R; Sanna M; Yao M; Robledo M; Neumann HP; Woodward ER; Latif F; Abbs S; Martin H; Maher ER
    Int J Endocrinol; 2015; 2015():138573. PubMed ID: 25883647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.
    Galan SR; Kann PH
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):165-75. PubMed ID: 23061808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
    Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
    Gimenez-Roqueplo AP; Dahia PL; Robledo M
    Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
    Fishbein L; Nathanson KL
    Cancer Genet; 2012; 205(1-2):1-11. PubMed ID: 22429592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
    de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
    Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations.
    Pillai S; Gopalan V; Lo CY; Liew V; Smith RA; Lam AK
    Exp Mol Pathol; 2017 Feb; 102(1):41-46. PubMed ID: 27986441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and Neck Paragangliomas-A Genetic Overview.
    Majewska A; Budny B; Ziemnicka K; Ruchała M; Wierzbicka M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma.
    Burnichon N; Buffet A; Parfait B; Letouzé E; Laurendeau I; Loriot C; Pasmant E; Abermil N; Valeyrie-Allanore L; Bertherat J; Amar L; Vidaud D; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2012 Dec; 21(26):5397-405. PubMed ID: 22962301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.